CA2996485A1 - Non-aqueous patch comprising lidocaine - Google Patents

Non-aqueous patch comprising lidocaine Download PDF

Info

Publication number
CA2996485A1
CA2996485A1 CA2996485A CA2996485A CA2996485A1 CA 2996485 A1 CA2996485 A1 CA 2996485A1 CA 2996485 A CA2996485 A CA 2996485A CA 2996485 A CA2996485 A CA 2996485A CA 2996485 A1 CA2996485 A1 CA 2996485A1
Authority
CA
Canada
Prior art keywords
lidocaine
patch
tape
patient
pharmacokinetic parameters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2996485A
Other languages
English (en)
French (fr)
Inventor
Tatsuya Mori
Naoyuki Saida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oishi Koseido Co Ltd
Itochu Chemical Frontier Corp
Original Assignee
Oishi Koseido Co Ltd
Itochu Chemical Frontier Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oishi Koseido Co Ltd, Itochu Chemical Frontier Corp filed Critical Oishi Koseido Co Ltd
Publication of CA2996485A1 publication Critical patent/CA2996485A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2996485A 2015-08-24 2016-08-24 Non-aqueous patch comprising lidocaine Abandoned CA2996485A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562208985P 2015-08-24 2015-08-24
US62/208,985 2015-08-24
PCT/JP2016/075376 WO2017034041A1 (en) 2015-08-24 2016-08-24 Non-aqueous patch comprising lidocaine

Publications (1)

Publication Number Publication Date
CA2996485A1 true CA2996485A1 (en) 2017-03-02

Family

ID=57121473

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2996485A Abandoned CA2996485A1 (en) 2015-08-24 2016-08-24 Non-aqueous patch comprising lidocaine

Country Status (17)

Country Link
US (2) US20180177742A1 (enExample)
EP (1) EP3331515A1 (enExample)
JP (3) JP2018525419A (enExample)
KR (1) KR20180042378A (enExample)
CN (2) CN113893231A (enExample)
AU (2) AU2016312038A1 (enExample)
BR (1) BR112018003617A2 (enExample)
CA (1) CA2996485A1 (enExample)
HK (1) HK1255255A1 (enExample)
IL (1) IL257529A (enExample)
MX (1) MX2018002191A (enExample)
PE (2) PE20181163A1 (enExample)
PH (1) PH12018500375A1 (enExample)
RU (1) RU2018110325A (enExample)
SG (1) SG10202007647YA (enExample)
WO (1) WO2017034041A1 (enExample)
ZA (1) ZA201801305B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186287B2 (en) 2022-05-02 2025-01-07 Hisamitsu Pharmaceutical Co., Inc. Lidocaine-containing patch

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
CA2835595C (en) 2011-05-10 2019-02-12 Itochu Chemical Frontier Corporation Non-aqueous patch
ES2845524T3 (es) 2011-09-27 2021-07-27 Itochu Chemical Frontier Corp Parche no acuoso
WO2020250144A2 (en) * 2019-06-10 2020-12-17 Azista Industries Pvt Ltd Lidocaine matrix adhesive patch and it's process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
CN101002759A (zh) * 2007-01-12 2007-07-25 陶燃 盐酸利多卡因和薄荷醇的透皮贴片制剂
CN101530401A (zh) * 2008-03-12 2009-09-16 中山市中健药物研究所有限公司 一种用于治疗急慢性炎性疼痛的复方透皮贴片
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
WO2010016219A1 (ja) * 2008-08-05 2010-02-11 株式会社メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
CA2835595C (en) * 2011-05-10 2019-02-12 Itochu Chemical Frontier Corporation Non-aqueous patch
ES2845524T3 (es) * 2011-09-27 2021-07-27 Itochu Chemical Frontier Corp Parche no acuoso

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186287B2 (en) 2022-05-02 2025-01-07 Hisamitsu Pharmaceutical Co., Inc. Lidocaine-containing patch

Also Published As

Publication number Publication date
PH12018500375A1 (en) 2018-08-29
HK1255255A1 (zh) 2019-08-09
RU2018110325A (ru) 2019-09-26
PE20240681A1 (es) 2024-04-10
WO2017034041A1 (en) 2017-03-02
RU2018110325A3 (enExample) 2020-01-20
JP2022133471A (ja) 2022-09-13
BR112018003617A2 (pt) 2018-12-11
KR20180042378A (ko) 2018-04-25
SG10202007647YA (en) 2020-09-29
MX2018002191A (es) 2018-06-06
JP2018525419A (ja) 2018-09-06
PE20181163A1 (es) 2018-07-19
JP2020114862A (ja) 2020-07-30
US20180177742A1 (en) 2018-06-28
CN108024979A (zh) 2018-05-11
US20200230073A1 (en) 2020-07-23
CN113893231A (zh) 2022-01-07
ZA201801305B (en) 2019-07-31
AU2022202121A1 (en) 2022-04-14
AU2016312038A1 (en) 2018-03-15
EP3331515A1 (en) 2018-06-13
IL257529A (en) 2018-04-30

Similar Documents

Publication Publication Date Title
US20200230073A1 (en) Non-aqueous patch comprising lidocaine
RU2713207C2 (ru) Трансдермальная композиция, содержащая донепезил в качестве активного ингредиента
JP5403948B2 (ja) メマンチン含有経皮吸収製剤
EP3569227B1 (en) Non-aqueous patch
TWI619518B (zh) 局部鞘胺醇－１－磷酸酯受體激動劑調配物及其使用方法
EP2829272B1 (en) Transdermal absorption preparation
US20100158990A1 (en) Transdermal method and patch for corticosteroid administration
JP7716111B2 (ja) 神経変性疾患の症状の緩和又は治療のための貼付剤
JP7495989B2 (ja) 局所用ナロキソン組成物およびそれを使用するための方法
CN106692112B (zh) 一种治疗局部软组织炎症疼痛的马钱子碱贴剂
JP5872060B2 (ja) Ｐｄｅ−５インヒビターの経皮送達を増強するための方法および改良された医薬組成物
US20230218538A1 (en) Transdermal patch
HK40088055A (zh) 用於缓解或治疗神经退行性疾病的症状的贴剂
TW201332592A (zh) 經皮吸收型製劑
US20180221299A1 (en) Transdermal delivery system
WO2001013938A1 (fr) Composition therapeutique pouvant etre administree par voie percutanee ou par les muqueuses

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210823

EEER Examination request

Effective date: 20210823

EEER Examination request

Effective date: 20210823

EEER Examination request

Effective date: 20210823

FZDE Discontinued

Effective date: 20240219